Shanghai, China Related Funds
| Fund Name | Location |
| AIMCo | Colorado, Denver, United States |
| Ant Group | China, Hangzhou, Zhejiang |
| Arctic Ventures | New York, New York, United States |
| Bayer Global Investments | - |
| Big Sky Partners | California, Sausalito, United States |
| Boussard & Gavaudan Holding | England, London, United Kingdom |
| Chainfund Capital | California, San Francisco, United States |
| Chengdushi Jinghan Shuma Tuwen Co., Ltd. | Chengdu, China, Sichuan |
| Electronic Soul Ventures | China, Hangzhou, Zhejiang |
| Endicott Group | New York, New York, United States |
| Future Capital | Frankfurt, Germany, Hessen |
| Glanzmann Enterprises | - |
| Indiana University Philanthropic Venture Fund | - |
| JUNQUANXIN Capital | Changning, China, Shanghai |
| KOEI TECMO CAPITAL | - |
| Life Sciences Research Partners V.Z.W. | - |
| Schwartzberg Cos. | - |
| SEI | SEI Ventures (NASDAQ: SEIC) | Oaks, Pennsylvania, United States |
| ST Telemedia | Central, Central Region, Singapore |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Orbiepharm | $3M | 25 Dec 2015 | Haidian District, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Orbiepharm | $3M | 25 Dec 2015 | Haidian District, Beijing, China |
